Articles From: Clinical Study Using Trovagene's Precision Cancer Monitoring Platform Published in Cancer Discovery to ClubCorp Announces Increase in Its Quarterly Cash Dividend by 8%


Prospective blinded study demonstrates ability to accurately determine mutational status and monitor response to BRAF inhibitor therapy from urinary cell-free DNA SAN DIEGO , Oct.
Sign-up for Clinical Study Using Trovagene's Precision Cancer Monitoring Platform Published in Cancer Discovery investment picks
http://media.marketwire.com/attachments/201112/37556_Genetic_Technologies_logo95.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1165552&ProfileId=051205&sourceType=1 MELBOURNE, AUSTRALIA --
Sign-up for Clinical Validation Study Supporting the Use of BREVAGenplus(R) in Breast Cancer Risk Assessment investment picks
Believes Business Combination could be achieved at a CSS share price of up to $34.00 NEW YORK , Nov.
Sign-up for Clinton Group Believes Merger Of CSS Industries And EveryWare Global Is In Best Interest Of All Shareholders investment picks
NEW YORK , Nov.
Sign-up for Clinton Group Highlights The Options Available To Wet Seal Today investment picks
http://media.marketwire.com/attachments/201009/645481_CLXlogo.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1167531&ProfileId=051205&sourceType=1 OAKLAND, CA --
Sign-up for Clorox Announces Feb. 4 Webcast of Second-Quarter Fiscal Year 2015 Results investment picks
http://media.marketwire.com/attachments/201009/645481_CLXlogo.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1160097&ProfileId=051205&sourceType=1 OAKLAND, CA --
Sign-up for Clorox Declares Regular Quarterly Dividend of 74 Cents per Share investment picks
Clorox Co.
Sign-up for Clorox Q1 profit, sales top estimates investment picks
Execution Shortcomings May Cost as Much as 50% of Potential Cumulative Cash Flow on New Growth Investments According to CEB ARLINGTON, Va.
Sign-up for Closing "Strategy-to-Execution Gaps" Key Factor for Companies to Achieve Growth Targets investment picks
2014/10/23
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0974514001&sourceType=1 http://media3.marketwire.com/logos/20120713-TC200.jpg MONTREAL, QUEBEC --
Sign-up for Closure of Transcontinental Concord and Transcontinental Edmonton Printing Plants investment picks
2014/11/17
Comcast Business today announced a data center and cloud program designed to provide customers with more efficient access to their own cloud solutions.
Sign-up for Cloud Applications Now More Accessible for Comcast Business Customers investment picks
2014/12/10
NaviSite, Inc. , a Time Warner Cable company, today announced the results of a recent survey that found cloud adoption within the enterprise has grown steadily, but that security and compliance remain key considerations when evaluating in-house and service provider options.
Sign-up for Cloud Infrastructure Services Survey Finds Reliability and Business Continuity are Driving Demand for Cloud Adoption, While Security Remains Top-of-Mind investment picks
Cloud Peak Energy Inc. (NYSE:CLD), one of the largest U.S. coal producers and the only pure-play Powder River Basin (“PRB”) coal company, today announced that Colin Marshall, Cloud Peak Energy’s President and Chief Executive Officer, will speak at the Cowen and Company 5th Annual Global Metals, Mining & Materials Conference at 2:10 p.m. (ET) on Wednesday, November 12, 2014 in New York, New York.
Sign-up for Cloud Peak Energy CEO to Speak at the Cowen and Company 5th Annual Global Metals, Mining & Materials Conference investment picks
Cloud Peak Energy Inc. (NYSE:CLD), one of the largest U.S. coal producers and the only pure-play Powder River Basin (“PRB”) coal company, today announced that Colin Marshall, Cloud Peak Energy’s President and Chief Executive Officer, will speak at the Goldman Sachs Annual Global Metals & Mining/Steel Conference at 4:00 p.m. (ET) on Thursday, November 20, 2014 in New York, New York.
Sign-up for Cloud Peak Energy CEO to Speak at the Goldman Sachs Annual Global Metals & Mining/Steel Conference investment picks
Cloud Peak Energy Inc. (NYSE: CLD) (“CPE Inc.”) announced that it has commenced a registered underwritten public offering of its Series A mandatory convertible preferred stock consisting of 100,000 shares with a liquidation preference of $1,000 per share.
Sign-up for Cloud Peak Energy Inc. Announces Public Offering of $100 Million of Mandatory Convertible Preferred Stock investment picks
Cloud Peak Energy Inc. (NYSE:CLD), one of the largest U.S. coal producers and the only pure-play Powder River Basin (“PRB”) coal company, today announced results for the third quarter and first nine months of 2014.
Sign-up for Cloud Peak Energy Inc. Announces Results for the Third Quarter and First Nine Months of 2014 investment picks
Cloud Peak Energy Inc. (NYSE:CLD), one of the largest U.S. coal producers and the only pure-play Powder River Basin (“PRB”) coal company, plans to announce its fourth quarter and full year 2014 financial results on February 17, 2015, after the markets close.
Sign-up for Cloud Peak Energy Inc. Announces Schedule for Fourth Quarter and Full Year 2014 Results investment picks
Cloud Peak Energy Inc. (NYSE:CLD) (“CPE Inc.”) announced that it has terminated the public offering of shares of its mandatory convertible preferred stock previously announced on November 18, 2014.
Sign-up for Cloud Peak Energy Inc. Announces Termination of Public Offering of Mandatory Convertible Preferred Stock investment picks
cloudBuy plc , the cloud eCommerce marketplace, is delighted to announce that it has signed an agreement with the Confederation of Indian Industry (CII) to develop a global trading platform.
Sign-up for cloudBuy Signs Agreement with Confederation of Indian Industry to Develop Global Trading Platform investment picks
SEATTLE, Washington and PALO ALTO, Calif., Oct.
Sign-up for Cloudera and EMC Launch Joint Solution for Seamless Integration Between EMC Isilon and Cloudera Enterprise Data Hub investment picks
Clovis Oncology, Inc. (NASDAQ: CLVS) announced today that its global Phase 2 study of lucitanib in patients with FGFR1-amplified squamous non-small cell lung cancer (NSCLC) has commenced and the first patient has been dosed at a U.S. study site.
Sign-up for Clovis Oncology Announces First Patient Enrolled in Lucitanib Phase 2 Study in Squamous Non-small Cell Lung Cancer investment picks
Clovis Oncology, Inc. (NASDAQ: CLVS) announced today that the Phase 2 portion of the seamless Phase 2/3 TIGER-1 ( T hird-Generation I nhibitor of Mutant E G FR in Lung Canc er ) study has commenced with the dosing of the first patient at a U.S. study site.
Sign-up for Clovis Oncology Announces First Patient Enrolled in TIGER-1 Study investment picks
Clovis Oncology , Inc. (NASDAQ:CLVS) reported financial results for its third quarter ended September 30, 2014, and provided an update on the Company’s clinical development programs for the rest of 2014.
Sign-up for Clovis Oncology Announces Third Quarter 2014 Operating Results investment picks
Clovis Oncology, Inc. (NASDAQ: CLVS) announced today that they have entered into a clinical trial collaboration with GlaxoSmithKline LLC to evaluate a novel combination therapy targeting mutant epidermal growth factor receptor (EGFR) non-small cell lung cancer (NSCLC). The Phase 1/2 trial of rociletinib given in combination with trametinib is planned to start in 1H 2015.
Sign-up for Clovis Oncology Enters into Oncology Clinical Trial Collaboration with GlaxoSmithKline investment picks
Clovis Oncology, Inc. (Nasdaq: CLVS) today announced that Patrick J.
Sign-up for Clovis Oncology to Present at the 2014 Credit Suisse Healthcare Conference investment picks
Clovis Oncology, Inc. (Nasdaq: CLVS) today announced that its Chief Executive Officer and President, Patrick J.
Sign-up for Clovis Oncology to Present at the 33rd Annual J.P. Morgan Healthcare Conference investment picks
2015/1/1
By Chester Yung Power generator CLP Holdings Ltd.
Sign-up for CLP Holdings: Sales of Two China Units Lapsed investment picks
DALLAS , Dec.
Sign-up for ClubCorp Announces Increase in Its Quarterly Cash Dividend by 8% investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: Clinical Study Using Trovagene's Precision Cancer Monitoring Platform Published in Cancer Discovery to ClubCorp Announces Increase in Its Quarterly Cash Dividend by 8%
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent